(71) observed that CAFs in breast cancer characterized by elevated levels of FOS-like antigen 2 could stimulate the sprouting of human umbilical vein endothelial cells independent of VEGF, leading to angiogenesis and tumor growth in vivo. This evidence concerns the gene VEGFA and breast carcinoma.